权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

2/2 Drug Development and Capacity Building: A UCR/CoH-CCC Partnership (ADMIN-CORE)

2/2 药物开发和能力建设：UCR/CoH-CCC 合作伙伴关系 (ADMIN-CORE)

基本信息

批准号：
10249140
负责人：
ERNEST MARTINEZ
金额：
$ 3.96万
依托单位：
UNIVERSITY OF CALIFORNIA RIVERSIDE
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
起止时间：
2019-09-02 至 2023-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10249140
关键词：
Achievement Address African American African American student Antelopes Asians California Cancer Center Support Grant Cancer Death Rates Cell Line Cellular biology Chicago City of Hope Comprehensive Cancer Center Clinical Trials Communities Conduct Clinical Trials Data Developmental Therapeutics Program Doctor of Medicine Doctor of Philosophy Documentation Ensure European Evaluation Faculty Funding Goals Grant Health Health Sciences Healthcare Hispanics Housing Illinois Joints K-Series Research Career Programs Latino Lead Leadership Logistics Minority Mission Monitor National Cancer Institute Not Hispanic or Latino Physicians Pilot Projects Policies Policy Developments Politics Postdoctoral Fellow Principal Investigator Publications Reporting Research Research Personnel Resources Safety Science Scientist Site Testing Therapeutic Time TimeLine Toxicology Training Translational Research Underrepresented Minority Universities anticancer research cancer health disparity clinical trial participant disparity elimination drug development drug discovery education research health disparity human subject protection improved meetings member minority communities novel therapeutics professor programs stem cells success translational research program

项目摘要

ABSTRACT The mission of the Administrative Core is to facilitate the capacity building and training mission of the University of California Riverside (UCR) - City of Hope Comprehensive Cancer Center (CoH-CCC) P20 Program. Both UCR and CoH-CCC are committed to providing the P20 PIs and investigators with necessary resources including protected time and clerical assistance. The Administrative Core will provide scientific leadership, administration, and fiscal management. The Core will be led by P20 PI's, Ernest Martinez, Ph.D. (UCR) and Victoria Seewaldt, M.D. (CoH). The P20 PI's are both R01 funded and are committed to training of underrepresented minorities. External Advisory Board (EAB) and Internal Advisory Board (IAB) will help guide our P20 planning, implementation, and evaluation. Together, we will develop initial plans, set priorities, and implement and evaluate whether we meet our P20 goals and milestones. Our EAB leaders are well-qualified to guide our P20 Partnership. EAB members are world leaders in the health science of disparities and lead their own P20 and U54 grants. EAB members include: Elana Martinez, Ph.D. (UC San Diego), Lucio Miele, M.D. (LSU), Ricardo Richardson, Ph.D. (NCCU), and Robert Winn, M.D. (University of Illinois, Chicago). EAB leaders will meet on site yearly to evaluate progress of the P20. Our IAB members are senior leaders within UCR and CoH-CCC. UCR IAB members include: Dr. Kelechi Kalu, Ph.D., Vice Provost and Professor of Political Science and Dr. Frances Sladek, Professor of Cell Biology and Toxicology. CoH-CCC IAB leaders include David Horne, Ph.D., CoH-CCC Developmental Therapeutics Program and Beckman Therapeutic Director and Linda Malkas, Ph.D., Dean of Translational Science and External Affairs CoH-CCC and Board of Directors California Stem Cell Translational Research Program. IAB and P20 leaders will meet quarterly, or more frequently if needed, to provide strategic direction, policy development, and evaluation of our P20 Partnership Project.

摘要行政核心的使命是促进能力建设和培训的使命加州大学滨江（UCR）- City of Hope综合癌症中心（CoH-CCC）P20 程序. UCR和CoH-CCC都致力于为P20 PI和研究者提供必要的资源，包括受保护的时间和文书援助。行政核心将提供科学的领导、行政和财务管理。核心将由P20 PI的Ernest Martinez博士领导。 (UCR)和医学博士维多利亚西瓦尔特。（CoH）. P20 PI都是R 01资助的，并致力于培训代表性不足的少数民族。外部咨询委员会（EAB）和内部咨询委员会（IAB）将帮助指导我们的P20规划，执行和评价。我们将共同制定初步计划，确定优先事项，并实施和评估我们是否实现了P20目标和里程碑。我们的EAB领导人非常有资格指导我们的P20伙伴关系。EAB成员是世界领先的健康科学的差距，并导致自己的P20和U 54赠款。EAB成员包括：Elana Martinez博士(UC San Diego），Lucio Miele，M.D. (LSU)理查德·理查森博士（NCCU）和罗伯特 Winn，医学博士（伊利诺伊大学，芝加哥）。EAB领导人将每年在现场开会，评估 P20。我们的IAB成员是UCR和CoH-CCC的高级领导人。UCR IAB成员包括：博士。 Kelechi Kalu博士，副教务长和政治学教授和弗朗西斯·斯莱德克博士，细胞教授生物学和毒理学。CoH-CCC IAB领导人包括大卫霍恩博士，CoH-CCC开发治疗项目和贝克曼治疗总监和琳达马尔卡斯博士，院长翻译科学和对外事务CoH-CCC和董事会加州干细胞转化研究程序. IAB和P20领导人将每季度举行一次会议，如果需要，可以更频繁地举行会议，以提供战略方向，政策制定和评估我们的P20伙伴关系项目。